Company Filing History:
Years Active: 2002-2003
Title: Martha Heider St Clair: Innovator in HIV Treatment
Introduction
Martha Heider St Clair is a notable inventor based in Rougemont, NC (US). She has made significant contributions to the field of HIV treatment through her innovative research and patented inventions. With a total of 3 patents, her work focuses on therapeutic combinations that enhance the effectiveness of HIV treatments.
Latest Patents
St Clair's latest patents include combinations comprising VX478, zidovudine, FTC, and/or 3TC for use in the treatments of HIV. This invention relates to therapeutic combinations that exhibit anti-HIV activity, including pharmaceutical compositions designed to treat infections with HIV mutants that show resistance to nucleoside and/or non-nucleoside inhibitors. Another significant patent involves combinations comprising VX478, zidovudine, and/or 1592U89, which also target HIV infections and aim to improve treatment outcomes.
Career Highlights
Throughout her career, Martha has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and GlaxoSmithKline LLC. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in HIV treatment.
Collaborations
One of her notable coworkers is David Walter Barry, with whom she has collaborated on various projects related to HIV research and treatment innovations.
Conclusion
Martha Heider St Clair's contributions to HIV treatment through her patented inventions highlight her dedication to improving healthcare outcomes. Her innovative work continues to impact the field significantly.